Literature DB >> 17107417

Pasteurella multocida pathogenesis: 125 years after Pasteur.

Marina Harper1, John D Boyce, Ben Adler.   

Abstract

Pasteurella multocida was first shown to be the causative agent of fowl cholera by Louis Pasteur in 1881. Since then, this Gram-negative bacterium has been identified as the causative agent of many other economically important diseases in a wide range of hosts. The mechanisms by which these bacteria can invade the mucosa, evade innate immunity and cause systemic disease are slowly being elucidated. Key virulence factors identified to date include capsule and lipopolysaccharide. The capsule is clearly involved in bacterial avoidance of phagocytosis and resistance to complement, while complete lipopolysaccharide is critical for bacterial survival in the host. A number of other virulence factors have been identified by both directed and random mutagenesis, including Pasteurella multocida toxin (PMT), putative surface adhesins and iron acquisition proteins. However, it is likely that many key virulence factors are yet to be identified, including those required for initial attachment and invasion of host cells and for persistence in a relatively nutrient poor and hostile environment.

Entities:  

Mesh:

Year:  2006        PMID: 17107417     DOI: 10.1111/j.1574-6968.2006.00442.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  92 in total

1.  Mucosal immunization provides better protection than subcutaneous immunization against Pasteurella multocida (B:2) in mice preimmunized with the outer membrane proteins.

Authors:  Subhash Kharb; Shiv Charan
Journal:  Vet Res Commun       Date:  2011-06-02       Impact factor: 2.459

2.  Pasteurella multocida toxin activation of heterotrimeric G proteins by deamidation.

Authors:  Joachim H C Orth; Inga Preuss; Ines Fester; Andreas Schlosser; Brenda A Wilson; Klaus Aktories
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-15       Impact factor: 11.205

3.  Crystal structure and immunogenicity of the class C acid phosphatase from Pasteurella multocida.

Authors:  Harkewal Singh; Thomas J Malinski; Thomas J Reilly; Michael T Henzl; John J Tanner
Journal:  Arch Biochem Biophys       Date:  2011-03-01       Impact factor: 4.013

4.  Pasteurella multocida specific bacteriophage suppresses P. multocida-induced inflammation: identification of genes related to bacteriophage signaling by Pasteurella multocida-infected swine nasal turbinate cells.

Authors:  Ga Young Park; Hyun Jin Yu; Jee Soo Son; Sang Joon Park; Hee-Jae Cha; Kyoung Seob Song
Journal:  Genes Genomics       Date:  2019-12-18       Impact factor: 1.839

5.  Pasteurella multocida toxin as a transporter of non-cell-permeating proteins.

Authors:  Stefan Bergmann; Doris Jehle; Carsten Schwan; Joachim H C Orth; Klaus Aktories
Journal:  Infect Immun       Date:  2013-04-29       Impact factor: 3.441

6.  Complete genome sequence of Pasteurella multocida HN06, a toxigenic strain of serogroup D.

Authors:  Wenjing Liu; Minjun Yang; Zhuofei Xu; Huajun Zheng; Wan Liang; Rui Zhou; Bin Wu; Huanchun Chen
Journal:  J Bacteriol       Date:  2012-06       Impact factor: 3.490

7.  Evaluation of immunogenicity and protective efficacy of recombinant ptfA of avian Pasteurella multocida.

Authors:  Q Gong; N Qu; M F Niu; C L Qin
Journal:  Iran J Vet Res       Date:  2016       Impact factor: 1.376

8.  In vitro and in vivo pathogenicity studies of Pasteurella multocida strains harbouring different ompA.

Authors:  Shailja Katoch; Mandeep Sharma; R D Patil; Sandeep Kumar; Subhash Verma
Journal:  Vet Res Commun       Date:  2014-03-07       Impact factor: 2.459

9.  Effector prediction in host-pathogen interaction based on a Markov model of a ubiquitous EPIYA motif.

Authors:  Shunfu Xu; Chao Zhang; Yi Miao; Jianjiong Gao; Dong Xu
Journal:  BMC Genomics       Date:  2010-12-01       Impact factor: 3.969

10.  The transcriptional response of Pasteurella multocida to three classes of antibiotics.

Authors:  Bindu Nanduri; Leslie A Shack; Shane C Burgess; Mark L Lawrence
Journal:  BMC Genomics       Date:  2009-07-14       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.